Kala Pharmaceuticals Inc. buy bundfuture
Start price
16.10.23
/
50%
€7.70
Target price
16.10.24
-
Performance (%)
-15.45%
End price
28.10.23
€6.51
Summary
This prediction ended on 28.10.23 with a price of €6.51. The price of Kala Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.45%. bundfuture has a follow-up prediction for Kala Pharmaceuticals Inc., but this time predicts that Kala Pharmaceuticals Inc. is a Sell. bundfuture has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kala Pharmaceuticals Inc. | 57.457% | 57.457% | -86.229% |
| iShares Core DAX® | 2.705% | -1.201% | 20.685% |
| iShares Nasdaq 100 | 4.127% | -2.559% | 11.088% |
| iShares Nikkei 225® | 1.944% | -4.238% | 14.312% |
| iShares S&P 500 | 2.919% | -0.468% | 4.416% |
According to bundfuture what are the pros and cons of Kala Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by bundfuture for this prediction
In the thread Kala Pharmaceuticals diskutieren
Buy Kala Pharmaceuticals Inc.
In the thread Trading Kala Pharmaceuticals
Buy beendet
Current prediction by bundfuture for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.54
17:55
17:55
-
01.12.26
01.12.26
-12.64%
07:37
07:37
Probably not worthwhile Investment
Stopped prediction by bundfuture for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.39
13.10.25
13.10.25
-
13.10.26
13.10.26
-49.78%
30.10.25
30.10.25
Probably not worthwhile Investment
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.56
28.09.25
28.09.25
-
28.09.26
28.09.26
-93.70%
29.09.25
29.09.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.58
31.08.25
31.08.25
-
31.08.26
31.08.26
61.15%
13.09.25
13.09.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.80
04.01.23
04.01.23
-
04.01.24
04.01.24
-33.71%
22.01.23
22.01.23

